Health Care & Life Sciences » Pharmaceuticals » Amgen | Top biotech companies R&D expenditure 2016

Top global biotech companies - R&D expenditure 2016

Select top global biotechnology companies' R&D expenditure in 2016 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data illustrates R&D expenditures of some of the global leading companies in biotechnology in 2016. In that year, Danish biopharmaceutical manufacturer Novo Nordisk was ranked fifth among such companies, spending almost 2.16 billion USD on research and development.

Roche (Switzerland)	11400
Gilead Sciences (U.S.)	5098
Celgene (U.S.)	4470
Amgen (U.S.)	3840
Novo Nordisk (Denmark)	2160
Regeneron (U.S.)	2052
Biogen (U.S.)	1973
Shire (UK)	1440
UCB (Belgium)	1130
Vertex (U.S.)	1048

Top global biotech companies - R&D expenditure 2016

StatInvestor